Initial experience and lessons learned with implementing Lutetium-177-dotatate radiopharmaceutical therapy in a radiation oncology –based program

To assist radiation oncology centers in implementing Lutetium-177-dotatate (177Lu) radiopharmaceutical therapy for midgut neuroendocrine tumors. Here we describe our workflow and how it was revised based on our initial experience on an expanded access protocol (EAP).

Source: Brachytherapy - August 16, 2020 Category: Cancer & Oncology Authors: Nichole M. Maughan, Hyun Kim, Yao Hao, Samantha Unangst, Michael C. Roach, Jose L. Garcia-Ramirez, Max Amurao, David Luechtefeld, Kinda Abdin, Michael B. Altman, Alexis Banks, Mary Riepe, Erica Bovard, Samantha Jenkins, Jacqueline E. Zoberi Source Type: research